Fucoidan is a sulfated, fucose-rich heteropolysaccharide extracted from brown seaweeds, widely recognized for its diverse biological activities, including anticoagulant, anticancer, anti-inflammatory, and antiviral effects.
Molecular Structure
Fucoidan is primarily composed of an α-L-fucose backbone linked through (1→3) and/or (1→4) glycosidic bonds, with sulfate ester groups predominantly located at the C-2 and/or C-4 positions. In addition to fucose, minor monosaccharide components such as galactose, xylose, mannose, uronic acids, and acetyl groups may be present. The sulfate content typically ranges from 5% to 38%, corresponding to a degree of sulfation between 0.2 and 2.0.
Structural features vary significantly depending on the algal source. For example, Fucus species produce galactofucoidans rich in fucose (~97%) with minor galactose content, whereas Laminaria species yield more flexible, high-molecular-weight chains (approximately 469 kDa). These structural variations are commonly characterized using nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and glycosidic linkage analysis.
Extraction and Properties
Fucoidan is typically extracted from brown algae such as Laminaria hyperborea and Sargassum fusiforme using hot water, acidic or alkaline treatments, or enzymatic digestion. Subsequent purification steps, including ethanol precipitation and dialysis, yield heterogeneous polysaccharide fractions with molecular weights ranging from 10 to 1000 kDa.
The physicochemical properties of fucoidan include high water solubility and a strong negative charge due to sulfate groups, which enhances interactions with proteins and growth factors. Fucoidan also exhibits antioxidant activity through free radical scavenging and demonstrates thermal stability. However, its structural heterogeneity remains a major challenge for standardization and clinical translation.
Biomedical Applications
Fucoidan displays significant biomedical potential through its ability to inhibit coagulation and complement activation via interactions with antithrombin. It also exerts anti-inflammatory effects by modulating cytokines and chemokines such as PDGF-BB and RANTES.
In cancer research, fucoidan has been shown to suppress tumor growth by inhibiting angiogenesis, inducing apoptosis, and modulating immune responses. Additional bioactivities include antiviral effects against HIV and SARS-CoV-2, hypolipidemic activity, and enhanced wound healing. These properties support its growing use in nutraceuticals, drug delivery systems, tissue engineering scaffolds, and other biomedical applications.
